Enrolling by invitation

SECPFMAPFMCreatine Supplementation for Fibromyalgia Symptoms

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Creatine

+ Dextrose

Dietary Supplement
Who is being recruted

Fibromyalgia+7

+ Muscular Diseases

+ Musculoskeletal Diseases

From 18 to 75 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Placebo-Controlled
Interventional
Study Start: February 2025
See protocol details

Summary

Principal SponsorCamilo Jose Cela University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 12, 2025

Actual date on which the first participant was enrolled.

This study is investigating whether creatine, a compound often used by athletes to improve performance, can help reduce pain and fatigue in people with Fibromyalgia. Fibromyalgia is a condition characterized by widespread pain and tiredness that affects many people and can be quite debilitating. The aim is to see if taking creatine can provide relief more quickly than seen in previous studies, potentially offering a new way to manage symptoms for those affected by this condition. Participants in the study will be given creatine to see if it helps alleviate their symptoms. Researchers will carefully monitor how the participants' pain and fatigue levels change over time. They will also examine any changes in muscle structure to better understand creatine's effects. By measuring these outcomes, the study hopes to provide valuable information on whether creatine can be an effective treatment for reducing Fibromyalgia symptoms, which could lead to more options for those seeking relief.

Official TitleStudy of the Effectiveness of Creatine on Pain, Fatigue, and Muscle Architectural Variables in Patients Witg Fibromyalgia.
NCT06675708
Principal SponsorCamilo Jose Cela University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

80 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

FibromyalgiaMuscular DiseasesMusculoskeletal DiseasesNervous System DiseasesNeurologic ManifestationsNeuromuscular DiseasesPainRheumatic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Criteria

3 inclusion criteria required to participate
Diagnosed with FM

aged between 18 and 75 years

agree to participate and sign the informed consent

4 exclusion criteria prevent from participating
who do not have recent surgeries

patients with reduced mobility

adequate level of comprehension to be able to answer the questionnaires that will be provided in the study

If they are taking antihypertensive medications

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
The creatine experimental group will receive 20g of creatine for 5 days, divided into 4 equal doses, followed by 5g/day as a single dose for the duration of the trial.

Group II

Placebo
The placebo group will receive 20g of dextrose for 5 days, divided into 4 equal doses, followed by 5g/day as a single dose for the duration of the trial

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

University Camilo José Cela

Madrid, SpainOpen University Camilo José Cela in Google Maps
Enrolling by invitationOne Study Center